QuiVad

Home / Funds / Keel Capital S.A., Sicav-Sif – Foghorn X2

Keel Capital S.A., Sicav-Sif – Foghorn X2

Every short position this fund has disclosed, market by market.

Follow

This fund discloses no open short position today.

Follow by RSS

Get the moves on Keel Capital S.A., Sicav-Sif – Foghorn X2 by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

155 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
September 27, 2019Cellavision ABSweden0.00%
September 26, 2019Bilia ABSweden0.00%
September 26, 2019Byggmax Group ABSweden0.00%
September 23, 2019Bilia ABSweden0.58%
September 22, 2019Bilia ABSweden0.58%
September 5, 2019Recipharm AB (publ)Sweden0.00%
September 2, 2019Byggmax Group ABSweden0.51%
September 1, 2019Byggmax Group ABSweden0.51%
August 26, 2019Byggmax Group ABSweden0.69%
August 26, 2019Recipharm AB (Publ)Sweden0.57%
August 25, 2019Byggmax Group ABSweden0.69%
August 25, 2019Recipharm AB (publ)Sweden0.57%
August 15, 2019Cellavision ABSweden0.50%
August 14, 2019Bilia ABSweden0.65%
August 14, 2019Cellavision ABSweden0.50%
August 13, 2019Bilia ABSweden0.65%
August 12, 2019Byggmax Group ABSweden0.75%
August 11, 2019Byggmax Group ABSweden0.75%
August 5, 2019Recipharm AB (Publ)Sweden0.69%
August 4, 2019Recipharm AB (publ)Sweden0.69%
August 2, 2019Bilia ABSweden0.79%
August 1, 2019Byggmax Group ABSweden0.88%
August 1, 2019Bilia ABSweden0.79%
August 1, 2019Skistar AktiebolagSweden0.63%August 1, 2019
August 1, 2019Cellavision ABSweden0.00%
July 31, 2019Byggmax Group ABSweden0.88%
July 31, 2019Skistar AktiebolagSweden0.63%
July 26, 2019Byggmax Group ABSweden0.97%
July 25, 2019Byggmax Group ABSweden1.05%
July 24, 2019Byggmax Group ABSweden1.05%
July 18, 2019Raysearch Laboratories AB (publ)Sweden0.00%
July 16, 2019Bilia ABSweden0.86%
July 15, 2019Bilia ABSweden0.86%
July 15, 2019Raysearch Laboratories AB (Publ)Sweden0.67%
July 14, 2019Raysearch Laboratories AB (publ)Sweden0.67%
July 10, 2019Bilia ABSweden0.90%
July 9, 2019Bilia ABSweden0.90%
July 9, 2019Recipharm AB (Publ)Sweden0.75%
July 9, 2019Raysearch Laboratories AB (Publ)Sweden0.70%
July 9, 2019Investment AB öresundSweden0.50%
July 8, 2019Byggmax Group ABSweden1.21%
July 8, 2019Raysearch Laboratories AB (Publ)Sweden0.80%
July 8, 2019Recipharm AB (publ)Sweden0.75%
July 8, 2019Investment AB öresundSweden0.50%
July 7, 2019Byggmax Group ABSweden1.21%
July 7, 2019Raysearch Laboratories AB (publ)Sweden0.80%
July 5, 2019Cellavision ABSweden0.51%
July 4, 2019Byggmax Group ABSweden1.11%
July 4, 2019Recipharm AB (Publ)Sweden0.82%
July 4, 2019Skistar AktiebolagSweden0.70%

Download 155 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Keel Capital S.A., Sicav-Sif – Foghorn X2, data as at September 27, 2019, https://www.quivad.com/detenteur/keel-capital-s-a-sicav-sif-foghorn-x2